FGF21 and metabolic dysfunction-associated steatotic liver disease: Based on the fact that CK18 is a marker of hepatocyte apoptosis and that FGF21 could be used as a marker of liver steatosis, this type of physical activity could act as method of prevention of NAFLD progression [85].